Skip to content
Screener

Danaher DHR Other developed markets — Sales

Other geography segments

North America
$2.47B+1.5%
High-growth markets
$1.96B+15.4%
Western Europe
$1.54B+2.2%

Similar metrics at other companies

Envista Holdings Corporation logo
NVSTOther developed markets — Sales
$34.5M+16.2%
Veralto logo
VLTOOther developed markets — Sales
$33M+13.8%
ITG
ITGROther Markets — Sales
$9.58M-47.3%
Envista Holdings Corporation logo
NVSTEmerging markets — Sales
$166M+10.4%
Veralto logo
VLTOHigh-growth markets — Sales
$388M+2.9%
DXP Enterprises logo
DXPEOther — Sales
$284K-36.7%

Other financials

Income statement

See full
Revenue$6.3B+5.5%
Gross profit$3.6B+2.5%
Operating income$1.1B+48.3%
Net income$870.0M+56.8%
EPS (diluted)$1.23+59.7%

Balance sheet

See full
Cash & equivalents$4.3B+47.0%
Total debt$27.9B+50.1%
Total equity$52.6B+0.5%
Total assets$92.4B+13.2%

Cash flow

See full
Operating cash flow$1.5B+14.6%
CapEx$269.0M+8.5%
Free cash flow$1.3B+16.1%

Valuation

See full
Market cap$140.36B+0.4%
Enterprise value$163.87B+5.5%
P/E35.1×-5.9×
P/S5.6×-0.2×

Profitability

See full
Gross margin58.5%-1.1pp
Operating margin20.4%+2.0pp
Net margin15.9%+1.7pp
FCF margin21.8%+1.5pp

Returns & leverage

See full
Return on equity7.6%+1.0pp
Debt / equity0.5×+0.2×
Current ratio1.7×0.0×

Where this comes from

Reported directly by Danaher in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The source filing: Danaher’s 10-Q, filed July 21, 2026.

Filed
Jul 20, 2026, 8:00 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0000313616-26-000161
For the Three-Month Period Ended June 26, 2026:Biotechnology / For the Three-Month Period Ended June 26, 2026:Life SciencesDiagnosticsTotal
Geographical region:
North America(a)$583$759$1,132$2,474
Western Europe6894214301,540
Other developed markets(b)7412693293
High-growth markets(c)5745738111,958
Total$1,920$1,879$2,466$6,265
Revenue type:
Recurring$1,722$1,268$2,210$5,200

Item 1. Financial Statements

FAQ

What is Danaher's other developed markets — sales?
Danaher (DHR) reported other developed markets — sales of $293M in Q2 2026.
How has Danaher's other developed markets — sales changed year-over-year?
Danaher's other developed markets — sales decreased by 0.3% year-over-year, from $294M to $293M.
What is the long-term trend for Danaher's other developed markets — sales?
Over 4 years (2021 to 2025), Danaher's other developed markets — sales has grown at a -2.0% compound annual growth rate (CAGR), from $1.36B to $1.25B.
What does other developed markets — sales mean?
This metric represents the total revenue generated from sales of products and services within developed geographic regions outside of the company's primary domestic or major regional markets. It reflects the company's ability to penetrate and maintain market share in mature economies that are not classified as the primary home market. Monitoring this revenue stream helps assess the geographic diversification and the stability of demand in advanced industrial and scientific markets.

Ask your AI about Danaher's other developed markets — sales.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude